What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His scientific interests lie mostly in Microbiology, Internal medicine, Mycosis, Immunology and Surgery.
His research ties Virulence and Microbiology together.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Amphotericin B, Voriconazole and Fluconazole.
His work deals with themes such as Cancer, Pharmacokinetics, Zygomycosis, Pathology and Breakthrough infection, which intersect with Mycosis.
His research in Surgery intersects with topics in Pharmacotherapy, Adverse effect and Combination therapy.
His research integrates issues of Infliximab and Transplantation in his study of Aspergillosis.
His most cited work include:
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial (395 citations)
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria (289 citations)
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
What are the main themes of his work throughout his whole career to date?
Dimitrios P. Kontoyiannis mainly investigates Internal medicine, Microbiology, Immunology, Aspergillosis and Surgery.
His biological study spans a wide range of topics, including Gastroenterology and Voriconazole.
In his study, which falls under the umbrella issue of Microbiology, Drosophila melanogaster is strongly linked to Virulence.
The Immunology study combines topics in areas such as Lung and Chemotherapy.
The various areas that Dimitrios P. Kontoyiannis examines in his Aspergillosis study include Amphotericin B, Mycosis and Intensive care medicine.
His Amphotericin B research incorporates themes from Itraconazole, Fluconazole and Pharmacology.
He most often published in these fields:
- Internal medicine (30.67%)
- Microbiology (33.04%)
- Immunology (22.96%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (30.67%)
- Microbiology (33.04%)
- In patient (9.48%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Microbiology, In patient, Intensive care medicine and Immunology.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Posaconazole.
His Virulence research extends to the thematically linked field of Microbiology.
His research integrates issues of Epidemiology, Immunosuppression, Disease, Antifungal and Transplantation in his study of Intensive care medicine.
His Cancer study combines topics from a wide range of disciplines, such as Surgery and Incidence.
Dimitrios P. Kontoyiannis interconnects In vitro, Aspergillosis and Aspergillus in the investigation of issues within Aspergillus fumigatus.
Between 2016 and 2021, his most popular works were:
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
- Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways. (121 citations)
- Guidelines and recommendations on yeast cell death nomenclature (78 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary areas of investigation include Internal medicine, Intensive care medicine, Gastroenterology, Immunology and Mucormycosis.
His Internal medicine research incorporates themes from Microbiome and Surgery.
His work carried out in the field of Gastroenterology brings together such families of science as Hematopoietic stem cell transplantation, Candida glabrata, Candida albicans and Hazard ratio.
His research investigates the connection between Candida albicans and topics such as Drosophila that intersect with problems in Microbiology.
The study incorporates disciplines such as Chemotherapy, Aspergillus and Cryptococcus neoformans in addition to Immunology.
Dimitrios P. Kontoyiannis focuses mostly in the field of Mucormycosis, narrowing it down to topics relating to Amphotericin B and, in certain cases, Surveillance study, Osteomyelitis and Mycosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
